Home> Products> monotherapy and adjunct therapy

{ "products": [ { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rasagail 0.5 ", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/rasagail-0-5-133622", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2024-06-26T07:22:12.294Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagail-0-5-/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604d847b387b17ecbcdf32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 5 ", "description": "LINALIGLIP 5 \nLinagliptin (5mg)\nIntroduction to LINALIGLIP 5\nLINALIGLIP 5 contains Linagliptin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Linagliptin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of LINALIGLIP 5\nEffective Blood Sugar Management\nPostprandial Glucose Control: LINALIGLIP 5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Linagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: LINALIGLIP 5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Linagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use LINALIGLIP 5\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 5 is one 5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-5-134269", "price": 225.0, "discountamount": 67.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "EMAIL", "class", "drugs", "water", "meals", "Order", "enzyme", "Action", "adults", "Dosing", "Support", "Overview", "patients", "readings", "Benefits", "Mechanism", "same time", "Compliance", "Guidelines", "full glass", "neuropathy", "LINALIGLIP", "Optimal Use", "Convenience", "information", "retinopathy", "Adjustments", "combination", "monotherapy", "Introduction", "Reduced Risk", "sterisonline", "best results", "sterispharma", "CALL/WHATSAPP", "daily routine", "typical dosage", "Administration", "one 5mg tablet", "treatment plan", "Consistent Use", "insulin release", "Linagliptin 5mg", "glucagon levels", "DPP-4 inhibitor", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "glucagon production", "individual response", "Complementary Therapy", "cardiovascular disease", "long-term complications", "lifestyle modifications", "consistent blood levels", "natural insulin response", "Overall Glycemic Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "natural incretin hormones", "Enhanced Insulin Response", "stable blood sugar levels", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1378, "imageuri": "https://productimages.withfloats.com/actual/66604d874f159c14e162a2e5.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604d874f159c14e162a2e5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:35:32.901Z", "updatedon": "2024-06-29T11:41:40.984Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//linaliglip-5-/1378", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 5 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 5", "Linagliptin (5mg)", "Linagliptin 5mg side effects", "Linagliptin 5 mg price", "Linagliptin 5 mg price in India", "linagliptin 5 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604a47870e7b20c49e422b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5 ", "description": "LINALIGLIP 2.5 \nLinagliptin 2.5 mg\nIntroduction to LINALIGLIP 2.5\nLINALIGLIP 2.5 contains Linagliptin 2.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Linagliptin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of LINALIGLIP 2.5\nEffective Blood Sugar Management\nPostprandial Glucose Control: LINALIGLIP 2.5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Linagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: LINALIGLIP 2.5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Linagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use LINALIGLIP 2.5\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5 is one 2.5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-134280", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "Order", "class", "EMAIL", "drugs", "water", "meals", "adults", "Dosing", "Action", "enzyme", "Support", "Overview", "Benefits", "patients", "readings", "Mechanism", "same time", "LINALIGLIP", "neuropathy", "Compliance", "full glass", "Guidelines", "Optimal Use", "information", "combination", "monotherapy", "Convenience", "retinopathy", "Adjustments", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "best results", "daily routine", "CALL/WHATSAPP", "Administration", "typical dosage", "treatment plan", "Consistent Use", "glucagon levels", "insulin release", "DPP-4 inhibitor", "one 2.5mg tablet", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "Linagliptin 2.5mg", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "glucagon production", "individual response", "Complementary Therapy", "cardiovascular disease", "lifestyle modifications", "long-term complications", "consistent blood levels", "Overall Glycemic Control", "natural insulin response", "type 2 diabetes mellitus", "meal) blood sugar levels", "natural incretin hormones", "stable blood sugar levels", "Enhanced Insulin Response", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitors", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1376, "imageuri": "https://productimages.withfloats.com/actual/66604a496030c166b1a78a3e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604a496030c166b1a78a3e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:21:43.142Z", "updatedon": "2024-06-29T12:00:41.066Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-2-5-/1376", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5", "Linagliptin 2.5 mg", "Linagliptin 2.5 mg uses", "Linagliptin 2.5 mg side effects", "Linagliptin 2.5 mg price", "Linagliptin 2.5 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66603f9f8da3a81d5c69fc6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN 50 ", "description": "GLISITAPTIN 50 \nSitagliptin Phosphate (50mg),\nIntroduction to GLISITAPTIN 50\nGLISITAPTIN 50 contains Sitagliptin Phosphate 50mg, a medication used primarily for the management of type 2 diabetes mellitus. Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to achieve better glycemic control in adults with type 2 diabetes.\n\nWhat is Sitagliptin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Sitagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Sitagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Sitagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of GLISITAPTIN 50\nEffective Blood Sugar Management\nPostprandial Glucose Control: GLISITAPTIN 50 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Sitagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN 50 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, GLISITAPTIN 50 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: GLISITAPTIN 50 is taken twice daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Sitagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use GLISITAPTIN 50\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN 50 is one 50mg tablet taken twice daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same times each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN 50 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-50-133866", "price": 395.0, "discountamount": 118.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "body", "diet", "Order", "EMAIL", "meals", "water", "enzyme", "adults", "Action", "Support", "Overview", "readings", "patients", "Benefits", "Mechanism", "full glass", "neuropathy", "Guidelines", "same times", "retinopathy", "Convenience", "monotherapy", "Adjustments", "combination", "information", "GLISITAPTIN", "Optimal Use", "Introduction", "Reduced Risk", "best results", "sterispharma", "sterisonline", "Daily Dosing", "daily routine", "CALL/WHATSAPP", "Administration", "Consistent Use", "treatment plan", "typical dosage", "glucagon levels", "insulin release", "one 50mg tablet", "DPP-4 inhibitor", "Compliance Twice", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "individual response", "glucagon production", "Complementary Therapy", "cardiovascular disease", "lifestyle modifications", "long-term complications", "consistent blood levels", "Overall Glycemic Control", "natural insulin response", "type 2 diabetes mellitus", "meal) blood sugar levels", "natural incretin hormones", "Enhanced Insulin Response", "stable blood sugar levels", "hepatic glucose production", "Sitagliptin Phosphate 50mg", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1368, "imageuri": "https://productimages.withfloats.com/actual/66603fa20c19ea48b9460e0f.png", "tileimageuri": "https://productimages.withfloats.com/tile/66603fa20c19ea48b9460e0f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:36:15.972Z", "updatedon": "2024-06-29T12:15:30.876Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisitaptin-50-/1368", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 50 ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN 50", "Sitagliptin Phosphate (50mg),", "Sitagliptin 50 mg price", "Sitagliptin side effects", "Sitagliptin 100 mg uses", "Sitagliptin 50 mg brands in India", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66603ba88e599e12c0ea9371", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISITAPTIN 100 ", "description": "GLISITAPTIN 100 \nSitagliptin Phosphate (100mg),\nIntroduction to GLISITAPTIN 100\nGLISITAPTIN 100 contains Sitagliptin Phosphate 100mg, a medication primarily used for the management of type 2 diabetes mellitus. Sitagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Sitagliptin?\nOverview of Sitagliptin\nSitagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Sitagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Sitagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Sitagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of GLISITAPTIN 100\nEffective Blood Sugar Management\nPostprandial Glucose Control: GLISITAPTIN 100 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Sitagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISITAPTIN 100 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, GLISITAPTIN 100 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: GLISITAPTIN 100 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Sitagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use GLISITAPTIN 100\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISITAPTIN 100 is one 100mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISITAPTIN 100 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisitaptin-100-133867", "price": 495.0, "discountamount": 148.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "Order", "class", "EMAIL", "drugs", "water", "meals", "adults", "Dosing", "Action", "enzyme", "Support", "Overview", "Benefits", "patients", "readings", "same time", "Mechanism", "neuropathy", "full glass", "Compliance", "Guidelines", "Optimal Use", "GLISITAPTIN", "information", "combination", "monotherapy", "Convenience", "retinopathy", "Adjustments", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "best results", "CALL/WHATSAPP", "daily routine", "Administration", "typical dosage", "treatment plan", "Consistent Use", "DPP-4 inhibitor", "glucagon levels", "insulin release", "DPP-4 Inhibition", "Exercise Adjunct", "one 100mg tablet", "excellent adjunct", "blood sugar spikes", "Recommended Dosage", "glucagon production", "healthcare provider", "individual response", "Complementary Therapy", "cardiovascular disease", "long-term complications", "lifestyle modifications", "consistent blood levels", "Overall Glycemic Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "natural insulin response", "natural incretin hormones", "stable blood sugar levels", "Enhanced Insulin Response", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Sitagliptin Phosphate 100mg", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitors", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1365, "imageuri": "https://productimages.withfloats.com/actual/66603baa8e77bb2c7154774f.png", "tileimageuri": "https://productimages.withfloats.com/tile/66603baa8e77bb2c7154774f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:19:20.28Z", "updatedon": "2024-06-29T12:24:16.629Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisitaptin-100-/1365", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 100 ", "category": "DIABETIC RANGE", "tags": [ "GLISITAPTIN 100", "Sitagliptin Phosphate (100mg),", "Sitagliptin phosphate 50 mg", "Sitagliptin 100 mg price", "Sitagliptin 50 mg uses", "Sitagliptin phosphate tablets uses", "Sitagliptin side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66603984e5c8fb18fc1936e8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISAXAPIN 5 ", "description": "GLISAXAPIN 5 \nSaxagliptin (5mg)\nIntroduction to GLISAXAPIN 5\nGLISAXAPIN 5 contains Saxagliptin 5mg, a medication primarily used for the management of type 2 diabetes mellitus. Saxagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Saxagliptin?\nOverview of Saxagliptin\nSaxagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Saxagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Saxagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Saxagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of GLISAXAPIN 5\nEffective Blood Sugar Management\nPostprandial Glucose Control: GLISAXAPIN 5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Saxagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISAXAPIN 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, GLISAXAPIN 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: GLISAXAPIN 5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Saxagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use GLISAXAPIN 5\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISAXAPIN 5 is one 5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISAXAPIN 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisaxapin-5-133432", "price": 285.0, "discountamount": 85.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "Order", "class", "EMAIL", "drugs", "water", "meals", "adults", "Dosing", "Action", "enzyme", "Support", "Overview", "Benefits", "patients", "readings", "Mechanism", "same time", "GLISAXAPIN", "neuropathy", "Compliance", "full glass", "Guidelines", "Optimal Use", "information", "combination", "monotherapy", "Convenience", "retinopathy", "Adjustments", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "best results", "daily routine", "CALL/WHATSAPP", "Administration", "typical dosage", "one 5mg tablet", "treatment plan", "Consistent Use", "Saxagliptin 5mg", "glucagon levels", "DPP-4 inhibitor", "insulin release", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "blood sugar spikes", "Recommended Dosage", "glucagon production", "healthcare provider", "individual response", "Complementary Therapy", "cardiovascular disease", "lifestyle modifications", "long-term complications", "consistent blood levels", "Overall Glycemic Control", "natural insulin response", "type 2 diabetes mellitus", "meal) blood sugar levels", "natural incretin hormones", "stable blood sugar levels", "Enhanced Insulin Response", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitors", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1361, "imageuri": "https://productimages.withfloats.com/actual/666039864f159c14e16219cd.png", "tileimageuri": "https://productimages.withfloats.com/tile/666039864f159c14e16219cd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:10:12.122Z", "updatedon": "2024-06-29T12:33:28.241Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisaxapin-5-/1361", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISAXAPIN 5 ", "category": "DIABETIC RANGE", "tags": [ "GLISAXAPIN 5", "Saxagliptin (5mg)", "Saxagliptin 5 mg uses", "Saxagliptin 5 mg Tablet price", "Onglyza 5 mg generic", "Saxagliptin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ed10e8da3a81d5c69dece", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 5/100 SR ", "description": "DAPA VILDA 5/100 SR \nDapagliflozin (5mg), Vildagliptin SR (100mg)\nDAPA VILDA 5/100 SR is a combination medication consisting of two active ingredients: Dapagliflozin (5mg) and Vildagliptin SR (100mg). Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, while Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor with sustained-release formulation.\n\nDapagliflozin works by inhibiting SGLT2 in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion, leading to lower blood glucose levels. Vildagliptin, on the other hand, acts by inhibiting DPP-4 enzyme, which prolongs the action of incretin hormones like GLP-1 and GIP, enhancing insulin secretion and suppressing glucagon release, ultimately reducing blood glucose levels.\n\nThis combination medication is indicated for the management of type 2 diabetes mellitus in adults. By targeting different pathways involved in glucose metabolism, DAPA VILDA 5/100 SR offers a comprehensive approach to glycemic control, helping patients achieve and maintain target blood glucose levels. It is typically prescribed as an adjunct to diet and exercise in patients whose diabetes is not adequately controlled with monotherapy or as a dual therapy option for those who require additional glucose-lowering agents.\n\nAs with any medication, DAPA VILDA 5/100 SR may cause side effects, including but not limited to urinary tract infections, genital mycotic infections, hypoglycemia, and gastrointestinal disturbances. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability.\n\nOverall, DAPA VILDA 5/100 SR offers a convenient once-daily dosing option and a synergistic approach to managing type 2 diabetes, helping patients achieve better glycemic control and potentially reducing the risk of long-term complications associated with uncontrolled diabetes. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive diabetes management plan tailored to the individual patient's needs and goals.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-5-100-sr-134362", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "risk", "part", "EMAIL", "goals", "needs", "Order", "GLP-1", "adults", "action", "target", "adjunct", "kidneys", "patients", "exercise", "other hand", "dapa-vilda", "convenient", "monotherapy", "information", "supervision", "hypoglycemia", "DPP-4 enzyme", "sterispharma", "side effects", "tolerability", "sterisonline", "CALL/WHATSAPP", "transporter 2", "Dapagliflozin", "sodium-glucose", "Vildagliptin SR", "adverse effects", "SGLT2) inhibitor", "glycemic control", "glucagon release", "DPP-4) inhibitor", "insulin secretion", "incretin hormones", "dosage adjustments", "individual patient", "different pathways", "glucose metabolism", "DAPA VILDA 5/100 SR", "individual response", "dual therapy option", "daily dosing option", "synergistic approach", "glucose reabsorption", "uncontrolled diabetes", "two active ingredients", "dipeptidyl peptidase-4", "comprehensive approach", "combination medication", "healthcare professional", "long-term complications", "urinary tract infections", "type 2 diabetes mellitus", "urinary glucose excretion", "genital mycotic infections", "lower blood glucose levels", "sustained-release formulation", "gastrointestinal disturbances", "additional glucose-lowering agents", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1274, "imageuri": "https://productimages.withfloats.com/actual/665ed12ffb1d1538612033fd.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ed12ffb1d1538612033fd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T08:32:14.71Z", "updatedon": "2024-06-04T08:32:14.71Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-5-100-sr-/1274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 5/100 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63c17e7475f0f453d4b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir (300mg), Emtricitabine (200mg) & Efavirenz (600 mg)", "description": "TELAVINCE EM is primarily indicated for the management of:\n\nHypertension (High Blood Pressure): Helps in reducing elevated blood pressure effectively.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of stroke, heart attack, and related complications.\n\nPatients requiring combination therapy: Suitable for individuals who need more than one antihypertensive for better blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE EM works through a dual mechanism to control blood pressure:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and reducing blood pressure.\n\n[EM Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThe combination ensures better efficacy than monotherapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral administration with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be modified based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not alter the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE EM:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces risk of cardiovascular events associated with hypertension.\n\nConvenient once-daily dosing improves patient compliance.\n\nWell-tolerated with a low incidence of side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should avoid use unless advised by a physician.\n\nAvoid excessive salt substitutes containing potassium.\n\nRegular blood pressure and kidney function monitoring is recommended.\n\nDo not use in combination with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nAlthough TELAVINCE EM is generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling in ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience severe side effects such as difficulty breathing, swelling of face or throat, or severe allergic reactions.\n\nStorage Instructions:\n\nStore in a cool, dry place away from direct sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE EM:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted name in pharmaceutical excellence.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for optimal patient compliance with convenient dosing.\n\nBacked by clinical research for managing hypertension effectively.\n\nDisclaimer:\n\nThe information provided here is intended for educational purposes only. TELAVINCE EM should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.", "price": 4715.0, "discountamount": 1415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2183, "imageuri": "https://productimages.withfloats.com/actual/68e63c1a4302b5c8207e2858.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e63c1a4302b5c8207e2858.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:25:27.075Z", "updatedon": "2025-10-08T10:36:46.57Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-300mg-emtricitabine-200mg-efavirenz-600-mg-/2183", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }